Skip to main content
. 2011 Mar;13(3):216–225. doi: 10.1016/j.micinf.2010.10.016

Table 4.

Baseline demographics and clinical outcome in 40 patients with infective endocarditis stratified by the FcγRIIa H131R platelet receptor polymorphism.

FcγRIIa H131R genotype
P valuea
H/H, n = 11 H/R, n = 19 R/R, n = 10
Age (y) 56 ± 13 59 ± 18 49 ± 21 0.470
Male (%) 6 (55) 15 (79) 9 (90) 0.149
Native valve (%) 8 (73) 10 (53) 8 (80) 0.279
Valvular heart disease (%) 7 (64) 5 (26) 2 (20) 0.061
Previous infective endocarditis (%) 3 (27) 2 (11) 1 (10) 0.408
Intravenous drug abuser (%) 0 3 (16) 1 (10) 0.381
Affected valve (%)
 Mitral 5 (45) 7 (37) 4 (40) 0.005
 Aortic 0 11 (58) 2 (20)
 Mitral + aortic 5 (45) 0 1 (10)
 Tricuspid ± mitral/aortic 1 (10) 1 (5) 2 (20)
 Pulmonary 0 0 1 (10)
Presence of vegetations (%) 9 (82) 14 (74) 8 (80) 0.856
Vegetation length, mmb 21 ± 14 13 ± 5 16 ± 7 0.166
Vegetation width, mmb 8 ± 2 8 ± 4 10 ± 5 0.946
Organism (%)
 Streptococci 4 (37) 6 (32) 5 (50) 0.545
 Staphylococci 2 (18) 6 (32) 3 (30)
 Streptococci + staphylococci 1 (9) 1 (5) 0
 Enterococci 2 (18) 0 0
 Other 1 (9) 4 (21) 2 (20)
 Culture negative 1 (9) 2 (10) 0
Surgery (%) 10 (91) 7 (37) 8 (80) 0.005
Embolic phenomena (%) 2 (18) 8 (42) 5 (50) 0.274
Heart failure (%) 6 (55) 6 (32) 0 0.024
Death (%) 4 (36) 5 (26) 0 0.118
Composite clinical end-point (%)c 10 (91%) 12 (63%) 8 (80%) 0.219
a

P values were determined using the Kruskal–Wallis test with Mann–Whitney U correction for numerical variables and the chi-squared test for categorical variables.

b

Data on vegetation characteristics were available for 30 of 31 subjects with vegetations.

c

The clinical end-point represents a composite of embolism, heart failure, need for surgery and mortality.

HHS Vulnerability Disclosure